Would you treat a completely resected Stage IA NSCLC EGFR exon 19 with adjuvant osimertinib alone omitting chemotherapy?

Do you offer adjuvant osimertinib to patients with resected Stage IA NSCLC EGFR exon 19 deletions?

• Yes, after adjuvant chemotherapy
• Yes, without adjuvant chemotherapy
• No, recurrence risk sufficiently low without any adjuvant treatment
• No, I only offer adjuvant chemotherapy
• Other